“`html
Apple’s Legal Battles with Masimo: A deep Dive
Table of Contents
Apple faced critically important legal setbacks on November 15, 2025, with a jury awarding $634 million to Masimo in a patent infringement case and the U.S. International Trade Commission (ITC) announcing a re-examination of a potential import ban on Apple Watches. These events mark a major escalation in a long-running legal dispute between the two companies, with perhaps far-reaching consequences for Apple’s wearable technology business.
The Core of the Dispute: Pulse Oximetry Technology
The conflict centers around Apple’s use of pulse oximetry technology in the Apple watch.Masimo, a medical technology company, holds patents related to non-invasive and accurate measurement of blood oxygen levels. Masimo alleges that Apple knowingly infringed upon these patents when developing the blood oxygen sensor feature in the Apple Watch series 6 and later models. Pulse oximetry is crucial for monitoring respiratory health, and its accuracy is paramount, especially in medical applications.
understanding Pulse oximetry
Pulse oximetry is a non-invasive method for measuring the oxygen saturation level of a person’s blood. It works by shining beams of light through the skin and measuring the amount of light absorbed by hemoglobin. Hemoglobin is the protein in red blood cells that carries oxygen. Oxygenated and deoxygenated hemoglobin absorb light differently, allowing the device to calculate the percentage of hemoglobin carrying oxygen. This technology is vital for diagnosing and monitoring conditions like sleep apnea, pneumonia, and chronic obstructive pulmonary disease (COPD).
The ITC Ruling and Potential Import Ban
In January 2024, the ITC initially ruled in favor of Masimo, finding that Apple did infringe on Masimo’s patents and issued an import ban on certain Apple Watch models. However, this ban was paused pending review. The ITC’s recent proclamation signals a renewed consideration of the import ban, potentially halting the sale of Apple Watches in the United States. The ITC’s role is to protect domestic industries from unfair competition, and patent infringement falls under this purview.
Why an Import Ban Matters
An import ban would be a substantial blow to Apple. The apple Watch is a key component of Apple’s wearable, home, and accessories segment, generating billions of dollars in revenue annually. In fiscal year 2024,this segment brought in over $80 billion. Losing access to the U.S. market, even temporarily, would significantly impact Apple’s financial performance and market share. Moreover, it could disrupt the supply chain and create uncertainty for consumers.
The $634 Million Jury Verdict
The jury’s decision to award Masimo $634 million in damages represents a significant financial penalty for Apple. The amount is based on the jury’s assessment of the royalties Apple shoudl have paid Masimo for using its patented technology. This verdict underscores the seriousness of the infringement and sends a strong message to Apple regarding intellectual property rights.
Damages and Royalties Explained
In patent infringement cases, damages are typically calculated based on lost profits or reasonable royalties. Lost profits represent the revenue Masimo would have earned if Apple had licensed the technology. Reasonable royalties are the amount a willing licensor and a willing licensee would have agreed upon in a hypothetical negotiation. The jury likely considered both factors when determining the $634 million figure.
Looking Ahead: Appeals and Potential Outcomes
Apple is expected to appeal both the ITC’s decision and the jury verdict. The appeals process could take months or even years to resolve. Possible outcomes include:
- Prosperous Appeal: Apple could overturn the rulings, avoiding the import ban and the financial penalty.
- Settlement: Apple and Masimo could reach a settlement agreement,potentially involving licensing fees and other concessions.
- Continued Litigation: The legal battle could continue, with further appeals and potential trials.
The outcome of this dispute will have significant implications for the wearable technology industry and the protection of intellectual property rights. It also highlights the increasing importance of medical-grade sensors in consumer electronics and the potential for legal challenges in this rapidly evolving field.